BDMDW
Baird Medical Investment Holdings Limited
Price Chart
Latest Quote
$0.04
| Previous Close | $0.04 |
| Open | $0.06 |
| Day High | $0.06 |
| Day Low | $0.04 |
| Volume | 3,254 |
Stock Information
| Total Debt | $19.39M |
| Cash Equivalents | $419K |
| Revenue | $22.54M |
| Net Income | $-27.28M |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Sales | $22.54M |
| Income | $-27.28M |
| Book/sh | $1.52 |
| Employees | 146 |
Financial Ratios
| Quick Ratio | 1.33 |
| Current Ratio | 1.70 |
| Debt/Eq | 62.10 |
Returns & Margins
| ROA | -21.70% |
| ROE | -77.60% |
| Gross Margin | 83.79% |
| Operating Margin | -104.14% |
| Profit Margin | -121.04% |
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
| P/B | 0.03 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.12 |
| SMA50 | $0.12 |
| RSI | nan |
| Shares Float | 4.66M |
| Volatility | -1.23 |
Performance History
| Week | +0.00% |
| Month | +0.00% |
| Quarter | +0.00% |
| YTD | -38.63% |
| 10 Years | -38.63% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-12 | $0.12 | 0 |
| 2026-06-11 | $0.12 | 0 |
| 2026-06-10 | $0.12 | 0 |
| 2026-06-09 | $0.12 | 0 |
| 2026-06-08 | $0.12 | 0 |
| 2026-06-05 | $0.12 | 0 |
| 2026-06-04 | $0.12 | 0 |
| 2026-06-03 | $0.12 | 0 |
| 2026-06-02 | $0.12 | 0 |
| 2026-06-01 | $0.12 | 0 |
| 2026-05-29 | $0.12 | 0 |
| 2026-05-28 | $0.12 | 0 |
| 2026-05-27 | $0.12 | 0 |
| 2026-05-26 | $0.12 | 0 |
| 2026-05-22 | $0.12 | 0 |
| 2026-05-21 | $0.12 | 0 |
| 2026-05-20 | $0.12 | 0 |
| 2026-05-19 | $0.12 | 0 |
| 2026-05-18 | $0.12 | 0 |
About Baird Medical Investment Holdings Limited
Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; and long and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, and uterine fibroids, as well as soft tissue ablation. It sells its products through third-party distributors. Baird Medical Investment Holdings Limited was founded in 2012 and is based in Guangzhou, China.
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $3,653,278 | $4,383,363 | $4,227,409 | $7,054,323 |
| Cost Of Revenue | $3,653,278 | $4,383,363 | $4,227,409 | $7,054,323 |
| Total Revenue | $22,537,016 | $37,037,108 | $31,457,908 | $35,091,174 |
| Operating Revenue | $22,537,016 | $37,037,108 | $31,457,908 | $35,091,174 |
| Expenses | ||||
| Interest Expense | $737,370 | $576,359 | $284,271 | $299,269 |
| Total Expenses | $48,074,427 | $21,721,804 | $18,804,224 | $20,084,010 |
| Other Income Expense | $-100,195 | $-651,657 | $-10,211 | $-194,580 |
| Other Non Operating Income Expenses | $-100,195 | $-651,657 | $-10,211 | $-194,580 |
| Net Non Operating Interest Income Expense | $-737,370 | $-576,359 | $-284,271 | $-290,716 |
| Interest Expense Non Operating | $737,370 | $576,359 | $284,271 | $299,269 |
| Operating Expense | $44,421,149 | $17,338,441 | $14,576,815 | $13,029,687 |
| Other Operating Expenses | $-93,394 | $-266 | $-791,959 | $-1,375,447 |
| Selling And Marketing Expense | $10,264,507 | $4,061,116 | $2,547,000 | $3,585,138 |
| General And Administrative Expense | $14,119,024 | $7,103,226 | $8,546,880 | $6,560,604 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-27,278,005 | $12,453,369 | $10,545,978 | $12,568,750 |
| Net Interest Income | $-737,370 | $-576,359 | $-284,271 | $-290,716 |
| Normalized Income | $-27,278,005 | $12,453,369 | $10,545,978 | $12,568,750 |
| Net Income From Continuing And Discontinued Operation | $-27,278,005 | $12,453,369 | $10,545,978 | $12,568,750 |
| Total Operating Income As Reported | $-25,630,805 | $15,315,038 | $11,861,725 | $13,631,717 |
| Average Dilution Earnings | $0 | $0 | $0 | $0 |
| Net Income Common Stockholders | $-27,278,005 | $12,453,369 | $10,545,978 | $12,568,750 |
| Net Income | $-27,278,005 | $12,453,369 | $10,545,978 | $12,568,750 |
| Net Income Including Noncontrolling Interests | $-27,541,124 | $12,598,098 | $10,658,183 | $12,774,971 |
| Net Income Continuous Operations | $-27,541,124 | $12,598,098 | $10,658,183 | $12,774,971 |
| Pretax Income | $-26,374,976 | $14,087,288 | $12,359,202 | $14,521,868 |
| Operating Income | $-25,537,411 | $15,315,304 | $12,653,684 | $15,007,164 |
| Gross Profit | $18,883,738 | $32,653,745 | $27,230,499 | $28,036,851 |
| Interest Income | - | $393 | $1,562 | $8,553 |
| Interest Income Non Operating | - | $393 | $1,562 | $8,553 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-24,533,522 | $15,802,778 | $13,657,860 | $16,291,168 |
| Reconciled Depreciation | $1,104,084 | $1,139,131 | $1,014,387 | $1,470,031 |
| EBITDA (Bullshit earnings) | $-24,533,522 | $15,802,778 | $13,657,860 | $16,291,168 |
| EBIT | $-25,637,606 | $14,663,647 | $12,643,473 | $14,821,137 |
| Diluted NI Availto Com Stockholders | $-27,278,005 | $12,453,369 | $10,545,978 | $12,568,750 |
| Minority Interests | $263,119 | $-144,729 | $-112,205 | $-206,221 |
| Tax Provision | $1,166,148 | $1,489,190 | $1,701,019 | $1,746,897 |
| Research And Development | $20,131,012 | $6,174,365 | $4,274,894 | $3,859,392 |
| Selling General And Administration | $24,383,531 | $11,164,342 | $11,093,880 | $10,145,742 |
| Other Gand A | $14,119,024 | $7,103,226 | $8,546,880 | $6,560,604 |
| Provision For Doubtful Accounts | - | $1,200,000 | $2,200,000 | $400,000 |
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $31,298,702 | $39,584,839 | $35,665,790 | $25,822,733 |
| Total Assets | $69,701,015 | $77,962,870 | $56,708,389 | $42,617,529 |
| Total Non Current Assets | $14,731,497 | $16,547,495 | $16,625,687 | $8,853,913 |
| Other Non Current Assets | $241,205 | $121,506 | $152,450 | $45,946 |
| Non Current Prepaid Assets | $7,113,014 | $8,021,046 | $7,698,728 | $5,762,918 |
| Non Current Deferred Assets | $762,289 | $714,461 | $1,689,630 | $206,221 |
| Non Current Deferred Taxes Assets | $762,289 | $714,461 | $814,372 | $206,221 |
| Goodwill And Other Intangible Assets | $68,929 | $74,299 | $84,854 | $110,621 |
| Other Intangible Assets | $8,626 | $16,527 | $25,479 | $49,481 |
| Current Assets | $54,969,518 | $61,415,375 | $40,082,702 | $33,763,616 |
| Other Current Assets | $240,547 | $295,754 | $120,485 | $196,999 |
| Restricted Cash | $387,496 | $0 | - | - |
| Prepaid Assets | $10,545,465 | $10,274,207 | $5,814,691 | $5,799,084 |
| Inventory | $1,085,783 | $1,296,577 | $1,142,569 | $1,293,249 |
| Receivables | $42,531,906 | $46,578,638 | $31,494,473 | $24,763,358 |
| Accounts Receivable | $42,528,919 | $46,575,776 | $31,099,891 | $24,371,640 |
| Allowance For Doubtful Accounts Receivable | $-4,756,474 | $-3,992,922 | $-2,841,192 | $-644,669 |
| Gross Accounts Receivable | $47,285,393 | $50,568,698 | $33,941,083 | $25,016,309 |
| Cash Cash Equivalents And Short Term Investments | $178,321 | $2,970,199 | $1,510,484 | $1,710,926 |
| Cash And Cash Equivalents | $178,321 | $2,970,199 | $1,510,484 | $1,710,926 |
| Cash Financial | $178,321 | $2,970,199 | $1,510,484 | $1,710,926 |
| Taxes Receivable | - | - | - | $0 |
| Debt | ||||
| Net Debt | $18,976,819 | $17,506,099 | $9,086,980 | $4,523,488 |
| Total Debt | $19,297,808 | $20,877,297 | $11,513,476 | $7,440,922 |
| Long Term Debt And Capital Lease Obligation | $6,113,891 | $3,579,209 | $2,025,700 | $816,878 |
| Long Term Debt | $6,086,254 | $3,442,526 | $1,613,579 | - |
| Current Debt And Capital Lease Obligation | $13,183,917 | $17,298,088 | $9,487,776 | $6,624,044 |
| Current Debt | $13,068,886 | $17,033,772 | $8,983,885 | $6,234,414 |
| Other Current Borrowings | $2,637,036 | $867,772 | $817,485 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $38,477,473 | $38,202,392 | $21,001,134 | $16,839,769 |
| Total Non Current Liabilities Net Minority Interest | $6,113,891 | $3,579,209 | $2,025,700 | $816,878 |
| Current Liabilities | $32,363,582 | $34,623,183 | $18,975,434 | $16,022,891 |
| Current Deferred Liabilities | $802,170 | $837,340 | $593,294 | $712,832 |
| Current Deferred Taxes Liabilities | $8,758 | $45,238 | $93,389 | $20,321 |
| Payables And Accrued Expenses | $18,377,495 | $16,487,755 | $8,894,364 | $8,686,015 |
| Payables | $15,633,193 | $13,969,580 | $8,029,677 | $8,581,067 |
| Other Payable | $5,841,452 | $6,139,760 | $2,923,286 | $2,549,210 |
| Total Tax Payable | $3,098,410 | $2,873,453 | $770,953 | $1,795,225 |
| Income Tax Payable | $462,575 | $79,167 | $448,230 | $714,466 |
| Accounts Payable | $1,805,042 | $1,252,667 | $550,188 | $215,863 |
| Equity | ||||
| Common Stock Equity | $31,367,602 | $39,659,109 | $35,750,644 | $25,933,354 |
| Preferred Stock Equity | $29 | $29 | - | - |
| Total Equity Gross Minority Interest | $31,223,542 | $39,760,478 | $35,707,255 | $25,777,760 |
| Stockholders Equity | $31,367,631 | $39,659,138 | $35,750,644 | $25,933,354 |
| Gains Losses Not Affecting Retained Earnings | $3,221,418 | $1,450,090 | $2,503,244 | $3,118,885 |
| Other Equity Adjustments | $3,221,418 | $1,450,090 | $2,503,244 | $3,118,885 |
| Retained Earnings | $-515,415 | $26,764,751 | $14,394,167 | $3,961,236 |
| Other | ||||
| Treasury Shares Number | $10,227,012 | $10,173,529 | - | - |
| Ordinary Shares Number | $30,752,370 | $25,555,096 | $25,555,096 | $35,450,219 |
| Share Issued | $40,979,382 | $35,728,625 | $25,555,096 | $35,450,219 |
| Tangible Book Value | $31,298,673 | $39,584,810 | $35,665,790 | $25,822,733 |
| Invested Capital | $50,522,742 | $60,135,407 | $46,348,108 | $32,167,768 |
| Working Capital | $22,605,936 | $26,792,192 | $21,107,268 | $17,740,725 |
| Capital Lease Obligations | $142,668 | $400,999 | $916,012 | $1,206,508 |
| Total Capitalization | $37,453,885 | $43,101,664 | $37,364,223 | $25,933,354 |
| Minority Interest | $-144,089 | $101,340 | $-43,389 | $-155,594 |
| Additional Paid In Capital | $28,658,524 | $11,441,712 | $18,850,677 | $18,850,292 |
| Capital Stock | $3,104 | $2,585 | $2,556 | $2,941 |
| Common Stock | $3,075 | $2,556 | $2,556 | $2,941 |
| Preferred Stock | $29 | $29 | $0 | - |
| Long Term Capital Lease Obligation | $27,637 | $136,683 | $412,121 | $816,878 |
| Current Deferred Revenue | $793,412 | $792,102 | $499,905 | $692,511 |
| Current Capital Lease Obligation | $115,031 | $264,316 | $503,891 | $389,630 |
| Line Of Credit | $10,431,850 | $16,166,000 | $8,166,400 | $6,234,414 |
| Current Accrued Expenses | $2,744,302 | $2,518,175 | $864,687 | $104,948 |
| Dueto Related Parties Current | $4,888,289 | $3,703,700 | $3,785,250 | $4,020,769 |
| Goodwill | $60,303 | $57,772 | $59,375 | $61,140 |
| Net PPE | $6,546,060 | $7,616,183 | $7,000,025 | $2,728,207 |
| Accumulated Depreciation | $-5,922,209 | $-4,594,574 | $-3,576,625 | $-2,664,623 |
| Gross PPE | $12,468,269 | $12,210,757 | $10,576,650 | $5,392,830 |
| Leases | $4,516,963 | $4,327,441 | $4,656,762 | $2,607,048 |
| Other Properties | $521,659 | $807,079 | $1,202,499 | $1,622,119 |
| Machinery Furniture Equipment | $7,429,647 | $7,076,237 | $4,717,389 | $1,163,663 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $511,000 | $717,312 | $312,871 | $477,345 |
| Work In Process | $200,045 | $230,355 | $313,352 | $330,755 |
| Raw Materials | $374,738 | $348,910 | $516,346 | $485,149 |
| Duefrom Related Parties Current | $2,987 | $2,862 | $394,582 | $391,718 |
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-1,386,347 | $-9,166,793 | $-3,658,452 | $-5,468,161 |
| Operating Activities | ||||
| Operating Cash Flow | $-1,344,032 | $-6,313,115 | $-1,019,964 | $485,968 |
| Cash Flow From Continuing Operating Activities | $-1,656,051 | $-6,681,379 | $-1,377,289 | $485,968 |
| Operating Gains Losses | - | - | - | $-5,421 |
| Investing Activities | ||||
| Capital Expenditure | $-42,315 | $-2,853,678 | $-2,638,488 | $-5,954,129 |
| Investing Cash Flow | $-42,315 | $-2,467,043 | $-2,652,618 | $-5,921,464 |
| Cash Flow From Continuing Investing Activities | $-42,315 | $-2,467,043 | $-2,652,618 | $-5,921,464 |
| Net Other Investing Changes | - | $386,635 | $-14,130 | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $2,900,000 | $0 | $0 |
| Financing Cash Flow | $-1,393,823 | $10,334,146 | $3,475,248 | $4,411,918 |
| Cash Flow From Continuing Financing Activities | $-1,393,823 | $10,334,146 | $3,475,248 | $4,411,918 |
| Net Other Financing Charges | $763,617 | $-2,879,090 | $-997,505 | $-46,397 |
| Net Common Stock Issuance | $0 | $2,900,000 | $0 | $0 |
| Common Stock Issuance | $0 | $2,900,000 | $0 | $0 |
| Cash Dividends Paid | - | - | - | $0 |
| Common Stock Dividend Paid | - | - | - | $0 |
| Other | ||||
| Repayment Of Debt | $-20,093,968 | $-11,790,544 | $-7,677,641 | $-4,606,925 |
| Issuance Of Debt | $17,936,528 | $22,103,780 | $12,150,394 | $9,065,240 |
| Interest Paid Supplemental Data | $737,671 | $576,752 | $285,833 | $243,838 |
| Income Tax Paid Supplemental Data | $836,584 | $1,837,708 | $2,644,786 | $1,439,558 |
| End Cash Position | $565,817 | $2,970,199 | $1,510,484 | $1,710,926 |
| Beginning Cash Position | $2,970,199 | $1,510,484 | $1,710,926 | $3,032,151 |
| Effect Of Exchange Rate Changes | $375,788 | $-94,273 | $-3,108 | $-297,647 |
| Changes In Cash | $-2,780,170 | $1,553,988 | $-197,334 | $-1,023,578 |
| Net Issuance Payments Of Debt | $-2,157,440 | $10,313,236 | $4,472,753 | $4,458,315 |
| Net Short Term Debt Issuance | $-6,266,455 | $8,340,000 | $2,118,000 | $4,458,315 |
| Short Term Debt Payments | $-17,811,755 | $-10,983,780 | $-7,483,600 | $-4,606,925 |
| Short Term Debt Issuance | $11,545,300 | $19,323,780 | $9,601,600 | $9,065,240 |
| Net Long Term Debt Issuance | $4,109,015 | $1,973,236 | $2,354,753 | $0 |
| Long Term Debt Payments | $-2,282,213 | $-806,764 | $-194,041 | $0 |
| Long Term Debt Issuance | $6,391,228 | $2,780,000 | $2,548,794 | $0 |
| Net PPE Purchase And Sale | $-42,315 | $-2,853,678 | $-2,638,488 | $-5,876,643 |
| Purchase Of PPE | $-42,315 | $-2,853,678 | $-2,638,488 | $-5,909,308 |
| Change In Working Capital | $6,790,782 | $-21,697,725 | $-14,846,981 | $-14,049,293 |
| Change In Other Working Capital | $-32,470 | $310,151 | $-173,101 | $45,449 |
| Change In Other Current Liabilities | $-268,367 | $-497,449 | $-253,605 | $389,481 |
| Change In Payables And Accrued Expense | $129,442 | $1,314,612 | $582,950 | $2,382,154 |
| Change In Accrued Expense | $-450,913 | $-1,567,492 | $1,213,891 | $1,343,230 |
| Change In Payable | $580,355 | $2,882,104 | $-630,941 | $1,038,924 |
| Change In Account Payable | $483,945 | $727,800 | $341,525 | $-100,934 |
| Change In Tax Payable | $96,410 | $2,154,304 | $-972,466 | $1,139,858 |
| Change In Income Tax Payable | $96,410 | $2,154,304 | $-972,466 | $1,139,858 |
| Change In Prepaid Assets | $1,353,849 | $-4,837,745 | $-5,442,379 | $-3,451,176 |
| Change In Inventory | $260,281 | $-187,543 | $113,661 | $1,568,326 |
| Change In Receivables | $5,348,047 | $-17,799,751 | $-9,674,507 | $-14,102,096 |
| Changes In Account Receivables | $5,348,047 | $-17,799,751 | $-9,674,507 | $-14,839,326 |
| Other Non Cash Items | $312,019 | $368,264 | $357,325 | - |
| Stock Based Compensation | $17,471,081 | $0 | $0 | - |
| Provisionand Write Offof Assets | $572,625 | $1,246,343 | $2,339,109 | $438,997 |
| Deferred Tax | $-53,499 | $32,774 | $-541,987 | $-143,317 |
| Deferred Income Tax | $-53,499 | $32,774 | $-541,987 | $-143,317 |
| Depreciation Amortization Depletion | $1,104,084 | $1,139,131 | $1,014,387 | $1,470,031 |
| Depreciation And Amortization | $1,104,084 | $1,139,131 | $1,014,387 | $1,470,031 |
| Amortization Cash Flow | $8,391 | - | - | - |
| Amortization Of Intangibles | $8,391 | - | - | - |
| Depreciation | $1,407,712 | $368,264 | $357,325 | $1,470,031 |
| Net Income From Continuing Operations | $-27,541,124 | $12,598,098 | $10,658,183 | $12,774,971 |
| Net Intangibles Purchase And Sale | - | $0 | $0 | $-44,821 |
| Purchase Of Intangibles | - | $0 | $0 | $-44,821 |
| Sale Of PPE | - | $0 | $0 | $32,665 |
| Change In Other Current Assets | - | $0 | $-9,102 | $-881,431 |
| Gain Loss On Sale Of PPE | - | $0 | $0 | $-5,421 |